Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.

导出 OA

翻译打印收藏纠错

作者： Jason,Bacharach ^[1] ; David L,Wirta ^[2] ; Robert,Smyth-Medina ^[3] ; Michael S,Korenfeld ^[4] ; Shane R,Kannarr ^[5] ; Shane,Foster ^[6] ; Mark,J Jaros ^[7] ; Charles B,Slonim ^[8]

作者单位： North Bay Eye Associates, Petaluma, CA, USA. ^[1] Aesthetic Eye Care Institute & Eye Research Foundation, Newport Beach, CA, USA. ^[2] North Valley Eye Medical Group, Mission Hills, CA, USA. ^[3] Comprehensive Eye Care, Ltd, Washington, MO, USA. ^[4] Kannarr Eye Care, Pittsburg, KS, USA. ^[5] Athens Eye Care, Athens, OH, USA. ^[6] Summit Analytical, Denver, CO, USA. ^[7] Department of Ophthalmology, University of South Florida Morsani College of Medicine, Tampa, FL, USA. ^[8]

关键词 Müller’s muscle alpha adrenergic agonist eye drop non-surgical pharmacologic topical

DOI 10.2147/OPTH.S306155

PMID 34211263

发布时间 2022-04-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical ophthalmology (Auckland, N.Z.)

2021年15卷

2743-2751页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.

Clinical ophthalmology (Auckland, N.Z.)

相似文献

Clinical ophthalmology (Auckland, N.Z.)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.

Clinical ophthalmology (Auckland, N.Z.)

相似文献

Clinical ophthalmology (Auckland, N.Z.)

相关期刊

检索历史清除